Diagnostics & Research
The Diagnostics & Research industry has a total of 63 stocks, with a combined market cap of $767.42 billion, total revenue of $155.97 billion and a weighted average PE ratio of 57.40.
Market Cap
767.42B
Revenue
155.97B
Profits
13.37B
PE Ratio
57.40
Profit Margin
8.57%
Dividend Yield
0.20%
63 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 225.48B | -0.39% | 728,497 | 42.49B |
| 2 | DHR | Danaher Corporation | 186.36B | -0.70% | 1,299,100 | 22.52B |
| 3 | A | Agilent Technologies, Inc. | 43.30B | -1.34% | 1,317,675 | 6.74B |
| 4 | IQV | IQVIA Holdings Inc. | 41.73B | -2.15% | 867,386 | 15.07B |
| 5 | IDXX | IDEXX Laboratories, Inc. | 41.54B | -1.33% | 372,364 | 3.72B |
| 6 | MTD | Mettler-Toledo International Inc. | 31.26B | -3.22% | 297,530 | 3.79B |
| 7 | ICLR | ICON PLC | 25.59B | -1.86% | 409,642 | 8.23B |
| 8 | WAT | Waters Corporation | 20.72B | -0.52% | 419,253 | 2.91B |
| 9 | ILMN | Illumina, Inc. | 17.96B | 2.03% | 1,664,900 | 4.49B |
| 10 | LH | Laboratory Corporation of America Holdings | 17.73B | 1.30% | 763,526 | 12.30B |
| 11 | DGX | Quest Diagnostics Incorporated | 15.64B | 1.70% | 1,071,061 | 9.29B |
| 12 | RVTY | Revvity, Inc. | 13.02B | 0.72% | 524,373 | 2.73B |
| 13 | NTRA | Natera, Inc. | 12.63B | -1.86% | 1,582,924 | 1.21B |
| 14 | MEDP | Medpace Holdings, Inc. | 12.06B | -0.24% | 165,939 | 1.96B |
| 15 | CRL | Charles River Laboratories International, Inc. | 11.73B | 0.13% | 404,138 | 4.11B |
| 16 | EXAS | Exact Sciences Corporation | 10.26B | 3.89% | 2,661,567 | 2.53B |
| 17 | QGEN | Qiagen N.V. | 9.81B | 1.65% | 627,330 | 1.94B |
| 18 | RDNT | RadNet, Inc. | 4.12B | 0.85% | 533,966 | 1.66B |
| 19 | SHC | Sotera Health Company | 3.22B | 3.08% | 1,184,276 | 1.08B |
| 20 | GH | Guardant Health, Inc. | 2.93B | 7.29% | 4,170,624 | 603.73M |
| 21 | OLK | Olink Holding AB (publ) | 2.92B | 0.81% | 61,064 | 170.89M |
| 22 | NEOG | Neogen Corporation | 2.78B | 4.14% | 2,021,356 | 929.24M |
| 23 | TWST | Twist Bioscience Corporation | 2.76B | 11.94% | 1,683,424 | 277.49M |
| 24 | MYGN | Myriad Genetics, Inc. | 2.26B | -2.12% | 1,073,757 | 774.20M |
| 25 | NEO | NeoGenomics, Inc. | 2.00B | -0.89% | 377,238 | 610.66M |
| 26 | VCYT | Veracyte, Inc. | 1.72B | 5.29% | 1,092,501 | 375.47M |
| 27 | LAB | Standard BioTools Inc. | 949.96M | 3.33% | 1,826,407 | 126.76M |
| 28 | OPK | OPKO Health, Inc. | 878.21M | -1.56% | 2,055,248 | 799.60M |
| 29 | CDNA | CareDx, Inc | 779.08M | 1.01% | 1,576,034 | 275.11M |
| 30 | CSTL | Castle Biosciences, Inc. | 669.47M | 0.04% | 175,572 | 250.73M |
| 31 | FLGT | Fulgent Genetics, Inc. | 664.02M | 2.02% | 150,522 | 287.53M |
| 32 | SERA | Sera Prognostics, Inc. | 288.22M | -1.73% | 49,283 | 206.00K |
| 33 | ME | 23andMe Holding Co. | 255.51M | 6.35% | 4,346,209 | 247.99M |
| 34 | BDSX | Biodesix, Inc. | 174.32M | -3.80% | 94,060 | 54.85M |
| 35 | NOTV | Inotiv, Inc. | 107.55M | 10.90% | 282,420 | 585.17M |
| 36 | FONR | FONAR Corporation | 102.76M | -3.79% | 25,839 | 102.42M |
| 37 | PRPH | ProPhase Labs, Inc. | 95.46M | 4.75% | 48,031 | 28.72M |
| 38 | ACRS | Aclaris Therapeutics, Inc. | 84.09M | 0.85% | 647,318 | 31.12M |
| 39 | BNR | Burning Rock Biotech Limited | 82.46M | 1.51% | 46,659 | 75.80M |
| 40 | PSNL | Personalis, Inc. | 79.99M | -1.91% | 260,524 | 74.15M |
| 41 | MDXH | MDxHealth SA | 79.14M | 4.69% | 25,834 | 75.33M |
| 42 | STIM | Neuronetics, Inc. | 76.79M | 1.99% | 121,259 | 73.23M |
| 43 | PRE | Prenetics Global Limited | 75.92M | 8.17% | 21,697 | 21.74M |
| 44 | VNRX | VolitionRx Limited | 72.05M | 5.85% | 309,757 | 797.03K |
| 45 | ENZ | Enzo Biochem, Inc. | 55.84M | 4.81% | 255,765 | 12.81M |
| 46 | TTOO | T2 Biosystems, Inc. | 38.60M | 18.81% | 617,506 | 7.18M |
| 47 | OCX | OncoCyte Corporation | 38.56M | -0.17% | 27,456 | 1.50M |
| 48 | AWH | Aspira Women's Health Inc. | 35.57M | -2.70% | 27,210 | 9.15M |
| 49 | XGN | Exagen Inc. | 28.46M | 6.49% | 188,041 | 55.73M |
| 50 | BIAF | bioAffinity Technologies, Inc. | 22.91M | -0.50% | 98,389 | 2.53M |
| 51 | DMTK | DermTech, Inc. | 21.47M | 0.34% | 106,131 | 15.30M |
| 52 | PMD | Psychemedics Corporation | 15.04M | 0.38% | 1,120 | 22.10M |
| 53 | MYNZ | Mainz Biomed B.V. | 14.66M | 1.52% | 37,857 | 895.48K |
| 54 | STRR | Star Equity Holdings, Inc. | 14.26M | -0.45% | 13,285 | 45.79M |
| 55 | TRIB | Trinity Biotech plc | 13.11M | -4.82% | 197,070 | 56.83M |
| 56 | CHEK | Check-Cap Ltd. | 12.75M | 0.46% | 28,582 | - |
| 57 | GENE | Genetic Technologies Limited | 11.16M | 6.55% | 9,908 | 5.78M |
| 58 | CNTG | Centogene N.V. | 11.14M | 4.96% | 74,730 | 55.72M |
| 59 | PRPO | Precipio, Inc. | 9.23M | 3.80% | 1,957 | 15.20M |
| 60 | XWEL | XWELL, Inc. | 7.74M | -0.54% | 5,833 | 30.11M |
| 61 | NDRA | ENDRA Life Sciences Inc. | 3.21M | -3.13% | 108,996 | - |
| 62 | APDN | Applied DNA Sciences, Inc. | 2.66M | -12.25% | 223,591 | 5.52M |
| 63 | ISPC | iSpecimen Inc. | 2.25M | -6.13% | 251,178 | 9.27M |